##  [Relapsing MS patients more satisfied with Novartis oral drug Gilenya® than standard injectable therapies, according to new study results at CMSC](/us-en/news/media-releases/relapsing-ms-patients-more-satisfied-novartis-oral-drug-gilenya-standard-injectable-therapies-according-new-study-results-cmsc-0 "Relapsing MS patients more satisfied with Novartis oral drug Gilenya® than standard injectable therapies, according to new study results at CMSC") 

  May 30, 2013